微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 5.44% | 43.92% | 77.2% | 21/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 3.07% | 35.24% | -59.66% | 21/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 7.61% | 38.62% | 17.62% | 36/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 6.47% | 34.23% | 71.16% | 39/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 3.78% | 21.94% | 66.52% | 43/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 2.27% | 74.62% | -58.65% | 39/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 5.49% | 149.55% | 13.9% | 58/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 4.82% | 223.49% | 55.48% | 58/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 3.1% | 302.6% | 138.46% | 60/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 1.3% | 208.33% | -40.91% | 67/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 2.2% | 160.61% | 47.65% | 96/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 1.49% | 77.38% | 93.51% | 100/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 0.77% | 1200% | 164.17% | 106/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | -1.2% | -1100% | 66.94% | 119/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | -3.63% | -1678.26% | -532.14% | 122/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 0.84% | -78.57% | 1300% | 106/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | -0.07% | -103.47% | -158.33% | 116/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 0.12% | -92.68% | -47.83% | 103/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 0.23% | -97.75% | -94.13% | 122/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 3.92% | -56.44% | 94.06% | 96/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 2.02% | -46.13% | 23.17% | 107/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 1.64% | 86.36% | -83.95% | 83/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 10.22% | 112.03% | 13.56% | 89/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 9% | 94.81% | 140% | 56/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 3.75% | 79.43% | 326.14% | 81/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 0.88% | 91.3% | -81.74% | 58/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 4.82% | 62.29% | 4.33% | 98/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 4.62% | 36.69% | 121.05% | 53/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 2.09% | 344.68% | 354.35% | 60/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 0.46% | -24.59% | -84.51% | 52/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 2.97% | 143.44% | -12.13% | 90/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 3.38% | 692.98% | 619.15% | 49/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 0.47% | 113.2% | -22.95% | 55/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 0.61% | -68.23% | -50% | 48/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 1.22% | -95.37% | 314.04% | 92/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | -0.57% | 2% | 83.99% | 47/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | -3.56% | -125.07% | -285.42% | 58/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 1.92% | -64.04% | -92.72% | 28/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 26.36% | 34.22% | 85.63% | 17/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-06-30 | 14.2% | -8.68% | -27.7% | 6/141 | 6.35% | 安图生物 | 28% | 行业排名> |